Michael Ulz
Stock Analyst at Morgan Stanley
(1.24)
# 3,231
Out of 4,402 analysts
546
Total ratings
39.5%
Success rate
-0.4%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Rated: Buy | $140 → $150 | $99.54 | +50.69% | 23 | Jun 11, 2026 | |
| VIR Vir Biotechnology | Rated: Buy | $23 → $27 | $8.52 | +216.90% | 23 | Jun 11, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | $25 | $6.68 | +274.25% | 33 | Jun 11, 2026 | |
| GUTS Fractyl Health | Maintained: Hold | $2 | $0.7239 | +176.28% | 16 | Jun 4, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | $13 | $3.01 | +331.89% | 21 | Jun 3, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $47 | $17.95 | +161.84% | 24 | Jun 3, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $2 | $0.7198 | +177.85% | 15 | Jun 3, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | $33 | $7.87 | +319.31% | 22 | Jun 3, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 | $289.39 | +27.86% | 42 | May 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $130 | $73.82 | +76.10% | 34 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $74.41 | +34.39% | 24 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $3 | $3.64 | -17.58% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.52 | +13.64% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $16.45 | +39.82% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 | $87.66 | +55.14% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $99 → $95 | $28.61 | +232.05% | 22 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.66 | +87.97% | 17 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 → $25 | $15.00 | +66.67% | 28 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.007 | +5,042.86% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $7.99 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $1.97 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $14.51 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.5 | $4.35 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.00 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9845 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $28.90 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $3.96 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $5.58 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $3 | $29.49 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $55.54 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.42 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.98 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.00 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $28.84 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $898.94 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $60 | $6.97 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.98 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $17.91 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.6777 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $7.82 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $8 | $0.0001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $40 | $3.65 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.13 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $125.87 | n/a | 1 | May 18, 2010 |
Mirum Pharmaceuticals
Jun 11, 2026
Rated: Buy
Price Target: $140 → $150
Current: $99.54
Upside: +50.69%
Vir Biotechnology
Jun 11, 2026
Rated: Buy
Price Target: $23 → $27
Current: $8.52
Upside: +216.90%
Silence Therapeutics
Jun 11, 2026
Reiterated: Buy
Price Target: $25
Current: $6.68
Upside: +274.25%
Fractyl Health
Jun 4, 2026
Maintained: Hold
Price Target: $2
Current: $0.7239
Upside: +176.28%
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: $13
Current: $3.01
Upside: +331.89%
Dyne Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: $47
Current: $17.95
Upside: +161.84%
Tenaya Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7198
Upside: +177.85%
Kyverna Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $33
Current: $7.87
Upside: +319.31%
Alnylam Pharmaceuticals
May 29, 2026
Maintained: Hold
Price Target: $370
Current: $289.39
Upside: +27.86%
Ionis Pharmaceuticals
May 28, 2026
Reiterated: Buy
Price Target: $130
Current: $73.82
Upside: +76.10%
May 27, 2026
Maintained: Buy
Price Target: $100
Current: $74.41
Upside: +34.39%
May 15, 2026
Downgraded: Sell
Price Target: $7 → $3
Current: $3.64
Upside: -17.58%
May 13, 2026
Maintained: Hold
Price Target: $4
Current: $3.52
Upside: +13.64%
May 8, 2026
Maintained: Hold
Price Target: $23
Current: $16.45
Upside: +39.82%
May 5, 2026
Reiterated: Buy
Price Target: $136
Current: $87.66
Upside: +55.14%
Apr 30, 2026
Rated: Buy
Price Target: $99 → $95
Current: $28.61
Upside: +232.05%
Mar 27, 2026
Maintained: Hold
Price Target: $5
Current: $2.66
Upside: +87.97%
Mar 26, 2026
Rated: Hold
Price Target: $20 → $25
Current: $15.00
Upside: +66.67%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.007
Upside: +5,042.86%
Mar 11, 2025
Maintained: Buy
Price Target: $5
Current: $7.99
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5
Current: $1.97
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $14.51
Upside: n/a
Aug 13, 2024
Maintained: Sell
Price Target: $0.5
Current: $4.35
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $9.00
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.9845
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $40
Current: $28.90
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $3.96
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $5.58
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7 → $3
Current: $29.49
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $55.54
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $23.98
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $29.00
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $28.84
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $340
Current: $898.94
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $69 → $60
Current: $6.97
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $16.98
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $37
Current: $17.91
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $5
Current: $0.6777
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $7.82
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: $15 → $8
Current: $0.0001
Upside: n/a
Mar 28, 2019
Maintained: Hold
Price Target: $3 → $40
Current: $3.65
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $6.13
Upside: n/a
May 18, 2010
Maintained: Buy
Price Target: $28
Current: $125.87
Upside: n/a